NRx Pharmaceuticals Announces Positive Recommendation to Continue Enrollment in the Ongoing Trial of NRX-101 in Patients with Suicidal Treatment-Resistant Bipolar Depression
/PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals", the "Company"), a clinical-stage CNS biopharmaceutical company, today reported...
United States Stephen Willard Source Nrx Pharmaceuticals Inc Prnewswire Nrx Pharmaceuticals Inc Nrx Pharmaceuticals Inc Access Program
Source: prnewswire.com